Cargando…
Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Biomarkers to aid diagnosis and delineate the progression of Parkinson’s disease are vital for targeting treatment in the early phases of the disease. Here, we aim to discover a multi-protein panel representative of Parkinson’s and make mechanistic inferences from protein expression profiles within...
Autores principales: | Winchester, Laura, Barber, Imelda, Lawton, Michael, Ash, Jessica, Liu, Benjamine, Evetts, Samuel, Hopkins-Jones, Lucinda, Lewis, Suppalak, Bresner, Catherine, Malpartida, Ana Belen, Williams, Nigel, Gentlemen, Steve, Wade-Martins, Richard, Ryan, Brent, Holgado-Nevado, Alejo, Hu, Michele, Ben-Shlomo, Yoav, Grosset, Donald, Lovestone, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856276/ https://www.ncbi.nlm.nih.gov/pubmed/36694577 http://dx.doi.org/10.1093/braincomms/fcac343 |
Ejemplares similares
-
Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
por: Winchester, Laura M., et al.
Publicado: (2018) -
Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank
por: Nevado-Holgado, Alejo J, et al.
Publicado: (2016) -
Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
por: Nevado-Holgado, Alejo J, et al.
Publicado: (2016) -
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
por: Westwood, Sarah, et al.
Publicado: (2017) -
ANMerge: A Comprehensive and Accessible Alzheimer’s Disease Patient-Level Dataset
por: Birkenbihl, Colin, et al.
Publicado: (2021)